HealthTech
Jeff Aronin Encouraged by Positive Topline Results from Pediatric Tourette Syndrome Clinical Study
Jeff Aronin, Founder, Chairman, and CEO of Paragon Biosciences, is encouraged by the promising topline results from a clinical study of ecopipam...
